Skip to main content

Table 1 Characteristics of 55 patients with pericardial effusion treated by surgery a

From: Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery

Variables Value
Age, years; mean (range) 57 (29 to 82)
Gender, n (%)  
Male 31 (56.4)
Female 24 (23.6)
Malignancy, n (%)  
Lung cancer 36 (65.5)
Hematologic malignancy 4
GI cancer 5
Breast cancer 6
Ovary cancer 1
Thyroid cancer 1
Cardiac sarcoma 1
Thymoma 1
Time to PE after cancer diagnosis. months 9 (0 to 180)
Dyspnea, n (%) 45 (81.8)
Electrocardiography, n (%)  
Normal 23 (41.8)
Abnormal 32 (58.2)
Sinus tachycardia 20
Low voltage 9
Atrial fibrillation 2
APC 1
Cardiac tamponade, n (%) 28 (50.9)
Ejection fraction, (%) 62% (48 to 75)
Prior pericardiocentesis, n (%) 15 (27.3)
Recurrence after pericardiocentesis, n 8
Maximum distance of pericardial space by CT, mm 32.25 (11.7 to 54.68)
Concomitant pleural effusion, n (%) 39 (70.9)
Mediastinal lymphadenopathy, n (%) 40 (72.7)
Prior radiotherapy of the chest, n (%) 22 (40)
Pericardial metastasis by CT, n (%) 20 (36.4)
Pulmonary thromboembolism, n (%) 3 (5.5)
Extrathoracic metastasis, n (%) 32 (58.2)
  1. APC, Atrial premature contraction; CT, Computed tomography; GI, Gastrointestinal; PE, Pericardial effusion.
  2. aData are presented as median (range) unless otherwise stated.